1H NMR-based metabolomics approach to evaluate the effect of Xue-Fu-Zhu-Yu decoction on hyperlipidemia rats induced by high-fat diet

被引：92

作者：

Song, Xingfang ^{[1
]}

Wang, Junsong ^{[1
]}

Wang, Pengran ^{[1
]}

Tian, Na ^{[1
]}

Yang, Minghua ^{[1
]}

Kong, Lingyi ^{[1
]}

机构：

[1] China Pharmaceut Univ, Dept Nat Med Chem, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China

来源：

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS | 2013年 / 78-79卷

基金：

美国国家科学基金会;

关键词：

Xue-Fu-Zhu-Yu decoction; Traditional Chinese medicines; Hyperlipidemia; Metabolomics; H-1 NMR spectroscopy; OPLS-DA; HMG-COA REDUCTASE; LIGUSTICUM-CHUANXIONG; OXIDATIVE STRESS; ENZYME; SUPPLEMENTATION; METABOLISM; GLUTAMINE; EXTRACT; ESTER; ACID;

D O I：

10.1016/j.jpba.2013.02.014

中图分类号：

O65 [分析化学];

学科分类号：

070302 ; 081704 ;

摘要：

An NMR-based metabolomics approach was conducted to holisticly explore the effect of XFZYD (a traditional Chinese medicine formula) on high-fat diet induced hyperlipidemia rats with one of the commonly used antihyperlipidemic agents, simvastatin as the positive control. NMR spectra from blood plasma combined with statistical analysis revealed compounds distinguishing hyperlipidemia rats from normal control rats. XFZYD could ameliorate hyperlipidemia by intervening in some major metabolic pathways, such as decreasing the accumulation of ketone body (beta-hydroxybutyrate) and acetyl-glycoproteins, enhancing glutathione (GSH) biosynthesis, partially reversing energy and lipid metabolism disturbance. Oral administration of XFZYD could also be helpful to hyperlipidemia rats in bettering the serum chemistry profile. The combined results demonstrated that XFZYD could ameliorate the hyperlipidemic symptoms in a global scale and restore the abnormal metabolic state to a near normal level in a time-dependent pattern. (C) 2013 Elsevier B.V. All rights reserved.

引用

页码：202 / 210

页数：9

共 35 条

[1] Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatiosis in patients with non-alcoholic fatty liver disease [J].